Acrivon Therapeutics

Acrivon is a clinical-stage oncology company with a unique precision medicine platform.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2022
Stage of Initial Investment
Series B
Initial Investment Year
2021
Acrivon Portco Hover Image